GSK, Scynexis partner to develop further Brexafemme for fungal infection

By NS Healthcare Staff Writer

31 Mar 23

Brexafemme is a novel oral glucan synthase inhibitor that works with a distinct mechanism of action where it…

PharmaceuticalsPartnerships and Licensing Agreements

Novartis, Bicycle Therapeutics partner for Bicycle radio-conjugates

By NS Healthcare Staff Writer

29 Mar 23

Bicycle Therapeutics will leverage its in-house phage platform to discover bicyclic peptide (Bicycle) to be developed into BRCs,…

PharmaceuticalsPartnerships and Licensing Agreements

BioNTech, OncoC4 collaborate on novel CTLA-4 antibody therapy

By NS Healthcare Staff Writer

21 Mar 23

The collaboration aims to develop and market OncoC4’s monoclonal antibody candidate, ONC-392, as a standalone, or combination therapy…

PharmaceuticalsPartnerships and Licensing Agreements

Janssen Biotech in-licenses RenLite platform from China’s Biocytogen

By NS Healthcare Staff Writer

09 Mar 23

Janssen and its affiliates will get a non-exclusive global license to use Biocytogen’s RenLite platform, and its core…

PharmaceuticalsPartnerships and Licensing Agreements

ModeX, Merck sign licensing deal worth up to $923m for EBV vaccine candidate

By NS Healthcare Staff Writer

09 Mar 23

MDX-2201 is ModeX Therapeutics’ preclinical nanoparticle vaccine candidate for Epstein-Barr virus, which is a member of the herpes…

PharmaceuticalsPartnerships and Licensing Agreements

Volastra in-licenses Amgen’s sovilnesib; secures $60m funding

By NS Healthcare Staff Writer

08 Mar 23

The financing, led by founding investors Polaris Partners and ARCH Venture Partners alongside Lilly, will support Volastra’s portfolio…

PharmaceuticalsPartnerships and Licensing Agreements

Lilly, Confo enter into global licensing agreement for peripheral pain drug

By NS Healthcare Staff Writer

03 Mar 23

Confo's CFTX-1554 is a novel inhibitor of the angiotensin II type 2 receptor (AT2R) intended for the treatment…

PharmaceuticalsPartnerships and Licensing Agreements

AbbVie, Capsida expand collaboration to develop genetic medicines for eye diseases

By NS Healthcare Staff Writer

24 Feb 23

Capsida will receive $70m, which includes upfront payments and potential equity investment, and is eligible to receive up…

PharmaceuticalsPartnerships and Licensing Agreements

Moderna, Life Edit collaborate on novel in-vivo gene editing therapies

By NS Healthcare Staff Writer

23 Feb 23

The collaboration combines Moderna's mRNA platform with Life Edit's gene editing technologies, including base editing capabilities, to advance…

PharmaceuticalsPartnerships and Licensing Agreements

Clexio partners with Genetika+ for antidepressant screening platform

By NS Healthcare Staff Writer

07 Feb 23

Genetika+ platform allows assessment of the functional effects of drugs directly on human neurons and comprises more than…

PharmaceuticalsPartnerships and Licensing Agreements